GenXAI Analytics IPO Day 2: GMP ₹10
Welcome back, investors! It’s Day 2 of the GenXAI Analytics SME IPO on the NSE, and we’re here to bring you the latest subscription numbers and Grey Market Premium (GMP) update. As of the close of Day 2, the subscription figures remain at a steady 0x across all categories – Retail, NII, and QIB. While this might seem quiet on the surface, let’s dive deeper into what it means for potential investors.
| Date | GMP | Est. Listing |
|---|---|---|
| 11 Jun | +₹3 | ₹113 |
| 10 Jun | +₹3 | ₹113 |
| 09 Jun | +₹3 | ₹113 |
| 08 Jun | +₹3 | ₹113 |
| 06 Jun | +₹4 | ₹114 |
Subscription Status
The subscription status for GenXAI Analytics IPO is currently showing zero applications across the board. This is quite common for many SME IPOs, especially in the initial days. Don’t let the 0x fool you just yet. Often, the bulk of the applications come in on the last day or two, particularly from retail investors who tend to make their decisions closer to the closing date. The absence of immediate NII (Non-Institutional Investor) or QIB (Qualified Institutional Buyer) interest at this stage doesn’t necessarily signal a lack of confidence. It could simply mean they are observing the market sentiment and waiting for more data points, or perhaps they have their strategies to apply closer to the deadline. For retail investors, this presents an opportunity to enter the IPO without immediate oversubscription pressure, though it’s crucial to monitor the final days.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 12.59x | |
| NII / HNI | 31.28x | |
| QIB | 17.58x | |
| Total | 17.07x |
| Date | Retail | NII | QIB | Total |
|---|---|---|---|---|
| 09 Jun | 12.59x | 31.28x | 17.58x | 17.07x |
| 08 Jun | 1.08x | 1.96x | 0.50x | 1.08x |
| 05 Jun | 0.42x | 1.24x | 0.50x | 0.60x |
GMP Update
Now, let’s talk about the Grey Market Premium (GMP). The current GMP for GenXAI Analytics stands at ₹10, which is unchanged from yesterday’s ₹10. The issue price is set at ₹110. With a current GMP of ₹10, the expected listing price is around ₹120 (Issue Price + GMP). This indicates a modest premium in the grey market, suggesting a potential listing gain of roughly 9% if the GMP holds steady until listing. While a ₹10 GMP isn’t a massive surge, it’s a positive sign that there’s still some demand, even if subdued. The fact that it has remained stable is encouraging, as it suggests a lack of significant downward pressure on demand in the unofficial market.
Should You Apply?
So, the big question: should you apply for GenXAI Analytics IPO? Based on the data available today, it’s a mixed bag. The zero subscription numbers on Day 2, while not alarming for an SME IPO, do warrant caution. You’ll want to keep a very close eye on the subscription levels as Day 3 progresses. The stable ₹10 GMP is a decent indicator of a potential listing gain, but it’s not a guarantee. Remember, GMPs can be volatile and are not official indicators of performance. As always, it’s wise to consult with SEBI-registered investment advisors who can provide personalized guidance based on your risk appetite and financial goals. The IPO period runs until June 9th, 2026, giving you ample time to assess the situation. The lot size is 1200 shares, so factor that into your investment calculations. The bottom line is to do your due diligence, monitor the subscription closely, and make an informed decision.
For a comprehensive look at the company and all the IPO details, you can check out: View Full GenXAI Analytics IPO Details